Molina Healthcare, Inc. (MOH)
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates through Medicaid, Medicare, Marketplace, and Other segments. The company was founded in 1980 and is headquartered in Long Beach, California.
- Ticker
- MOH
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Market cap
- $11.50B
- 52-week range
- $121.06 - $244.89
Valuation
- Share price
- $206.56 (close of Nov 18, 2026)
- P/E (TTM)
- -368.68x
- Price to book
- 2.77x
- Price to free cash flow
- 48.33x
- Enterprise value
- $10.97B
- Book value per share
- $79.90
Price performance
| Period | Change |
|---|---|
| 1 day | -6.62% |
| 5 days | -1.29% |
| 1 month | -0.39% |
| 3 months | +1.45% |
| 6 months | +11.73% |
| Year to date | +19.03% |
| 1 year | +46.30% |
| 3 years | -41.54% |
| 5 years | -32.70% |
| 10 years | +294.79% |
| All time | +1,449.20% |
Short interest
- As of
- Oct 30, 2026
- Short % of float
- 6.50%
- Shares short
- 2.92M
- Days to cover
- 2.89
- Change since prior report
- -2.55%
- Source
- FINRA consolidated short interest
Members of Congress who disclosed MOH trades
Gilbert Ray Cisneros · Byron Donalds · Robert Bresnahan
Super investors holding MOH
Bill Nygren (Harris Associates LP) · Seth Klarman (Baupost Group) · Ken Griffin (Citadel) · Michael Burry (Scion Asset Mgmt) · Ray Dalio (Bridgewater Associates) · Lee Ainslie (Maverick Capital LTD)
Profitability and growth
- Return on equity
- 11.60%
- Return on assets
- 3.03%
- Net margin
- 1.04%
- Revenue growth
- 11.75%
- Net income growth
- -59.97%
- Free cash flow growth
- -216.91%
Cash flow and balance sheet
- Free cash flow yield (TTM)
- 2.07%
- Current ratio
- 1.69x
- Net debt to EBITDA
- -1.59x
Latest reported year
- Period end
- Dec 31, 2025
- Fiscal year
- 2025
- Revenue
- $45.43B
- Net income
- $472.00M
- Earnings per share
- $8.93
- Interest expense
- $192.00M
- Shares outstanding
- 52.80M
Income statement by year
| Period end | Revenue | Net income | EPS |
|---|---|---|---|
| 2025-12-31 | $45.43B | $472.00M | $8.93 |
| 2024-12-31 | $40.65B | $1.18B | $20.52 |
| 2023-12-31 | $34.07B | $1.09B | $18.91 |
| 2022-12-31 | $31.97B | $792.00M | $13.72 |
| 2021-12-31 | $27.77B | $659.00M | $11.40 |
| 2020-12-31 | $19.42B | $673.00M | $11.40 |
| 2019-12-31 | $16.83B | $737.00M | $11.85 |
| 2018-12-31 | $18.89B | $707.00M | $11.57 |
| 2017-12-31 | $19.88B | -$512.00M | -$9.07 |
| 2016-12-31 | $17.78B | $52.00M | $0.93 |
Margins and returns by year
| Period end | Net margin | Return on equity |
|---|---|---|
| 2025-12-31 | 1.04% | 11.60% |
| 2024-12-31 | 2.90% | 26.22% |
| 2023-12-31 | 3.20% | 25.88% |
| 2022-12-31 | 2.48% | 26.72% |
| 2021-12-31 | 2.37% | 25.06% |
| 2020-12-31 | 3.46% | 32.11% |
| 2019-12-31 | 4.38% | 37.60% |
| 2018-12-31 | 3.74% | 42.93% |
| 2017-12-31 | -2.58% | -38.29% |
| 2016-12-31 | 0.29% | 3.15% |
Cash and debt by year
| Period end | Cash | Debt |
|---|---|---|
| 2025-12-31 | $4.25B | $3.77B |
| 2024-12-31 | $4.66B | $2.92B |
| 2023-12-31 | $4.85B | $2.18B |
| 2022-12-31 | $4.01B | $2.18B |
| 2021-12-31 | $4.44B | $2.17B |
| 2020-12-31 | $4.15B | $2.13B |
| 2019-12-31 | $2.45B | $1.24B |
| 2018-12-31 | $2.83B | $1.02B |
| 2017-12-31 | $3.19B | $1.32B |
| 2016-12-31 | $2.82B | $975.00M |
Free cash flow by year
| Period end | Free cash flow | Stock-based compensation |
|---|---|---|
| 2025-12-31 | -$636.00M | $47.00M |
| 2024-12-31 | $544.00M | $116.00M |
| 2023-12-31 | $1.58B | $115.00M |
| 2022-12-31 | $682.00M | $103.00M |
| 2021-12-31 | $2.04B | $72.00M |
| 2020-12-31 | $1.82B | $57.00M |
| 2019-12-31 | $377.00M | $39.00M |
| 2018-12-31 | -$344.00M | $27.00M |
| 2017-12-31 | $718.00M | $46.00M |
| 2016-12-31 | $497.00M | $26.00M |
Investor relations
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|---|---|
| 2026-10-21 | Sep 2026 | $0.72 |
| 2026-07-22 | Jun 2026 | $1.37 |
| 2026-04-22 | Mar 2026 | $1.57 |
| 2026-02-05 | Dec 2025 | $0.43 |
| 2025-10-22 | Sep 2025 | $3.97 |
| 2025-07-23 | Jun 2025 | $5.50 |
| 2025-04-23 | Mar 2025 | $5.86 |
| 2025-02-05 | Dec 2024 | $5.81 |
Filings and sources
- Company website
- molinahealthcare.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
Centene Corp (CNC) · Humana Inc (HUM) · Cigna Group (CI) · Elevance Health, Inc. (ELV) · CVS Health Corp (CVS) · UnitedHealth Group Inc (UNH) · Veeva Systems Inc (VEEV) · HealthEquity, Inc. (HQY)
Understanding these figures
Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades